Peak Bio, Inc.
DelistedCIK 1834645fmd_06YXZ7GSDMXQCSFX18EQMQ715PManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2021 to Sep 30, 2024, 15 periods
| Line item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Total revenues | 1 | 1 | 0 |
| Research and development | 7 | 4 | 2 |
| Total operating expenses | 10 | 12 | 13 |
| Operating income | (9) | (12) | (13) |
| Interest expense | 0 | 0 | 3 |
| Interest and investment income | 0 | 0 | 0 |
| Other non-operating income (expense) | 1 | (1) | 0 |
| Income before taxes | (8) | (13) | (13) |
| Income tax expense | 0 | (0) | 0 |
| Net income from continuing operations | (8) | (13) | (13) |
| Net income | (8) | (13) | (13) |